BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 33394848)

  • 1. One-Year Follow-up of Pars Plicata Versus Pars Plana Application of Transscleral Micropulse Cyclophotocoagulation.
    Waibel S; Herber R; Pillunat LE; Pillunat KR
    J Glaucoma; 2021 Apr; 30(4):340-346. PubMed ID: 33394848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transscleral cyclophotocoagulation with MicroPulse
    Fili S; Kontopoulou K; Vastardis I; Perdikakis G; Papadonta SA; Armeni EZ; Kohlhaas M
    Int Ophthalmol; 2021 Apr; 41(4):1271-1282. PubMed ID: 33392944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Micropulse transscleral cyclophotocoagulation using a standard protocol in patients with refractory glaucoma naive of cyclodestruction.
    Souissi S; Baudouin C; Labbé A; Hamard P
    Eur J Ophthalmol; 2021 Jan; 31(1):112-119. PubMed ID: 31544505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early results of micropulse transscleral cyclophotocoagulation for the treatment of glaucoma.
    Nguyen AT; Maslin J; Noecker RJ
    Eur J Ophthalmol; 2020 Jul; 30(4):700-705. PubMed ID: 30938190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transscleral cyclophotocoagulation with MicroPulse® laser versus cyclophotocoagulation with continuous diode laser in patients with open-angle glaucoma.
    Fili S; Vastardis I; Perdikakis G; Kohlhaas M
    Int Ophthalmol; 2022 Feb; 42(2):525-539. PubMed ID: 34596834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of total energy delivery on success rate after contact diode laser transscleral cyclophotocoagulation: a retrospective case review and meta-analysis.
    Hauber FA; Scherer WJ
    J Glaucoma; 2002 Aug; 11(4):329-33. PubMed ID: 12169970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of Micropulse Transscleral Cyclophotocoagulation in Eyes With Good Central Vision.
    Varikuti VNV; Shah P; Rai O; Chaves AC; Miranda A; Lim BA; Dorairaj SK; Sieminski SF
    J Glaucoma; 2019 Oct; 28(10):901-905. PubMed ID: 31385915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphological Changes and Potential Mechanisms of Intraocular Pressure Reduction after Micropulse Transscleral Cyclophotocoagulation in Rabbits.
    Tsujisawa T; Ishikawa H; Uga S; Asakawa K; Kono Y; Mashimo K; Shoji N
    Ophthalmic Res; 2022; 65(5):595-602. PubMed ID: 32739916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new approach for CW-TSCPC to improve its safety and efficacy in glaucoma treatment.
    Ezzouhairi SM; Naciri L; Mba T; Jomaa R
    J Fr Ophtalmol; 2022 Jan; 45(1):93-103. PubMed ID: 34836701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of micropulse transscleral cyclophotocoagulation in primary open-angle glaucoma, pseudoexfoliation glaucoma, and secondary glaucoma.
    Tekeli O; Köse HC
    Eur J Ophthalmol; 2021 May; 31(3):1113-1121. PubMed ID: 32228050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Micropulse Trans-scleral Cyclophotocoagulation in Patients With Glaucoma: 1- and 2-Year Treatment Outcomes.
    de Crom RMPC; Slangen CGMM; Kujovic-Aleksov S; Webers CAB; Berendschot TTJM; Beckers HJM
    J Glaucoma; 2020 Sep; 29(9):794-798. PubMed ID: 32459690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoscopic Cyclophotocoagulation and Pars Plana Ablation (ECP-plus) to Treat Refractory Glaucoma.
    Tan JC; Francis BA; Noecker R; Uram M; Dustin L; Chopra V
    J Glaucoma; 2016 Mar; 25(3):e117-22. PubMed ID: 26020690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Micropulse Transscleral Diode Laser Cyclophotocoagulation in Refractory Glaucoma: Short-Term Efficacy, Safety, and Impact of Surgical History on Outcomes.
    Garcia GA; Nguyen CV; Yelenskiy A; Akiyama G; McKnight B; Chopra V; Lu K; Huang A; Tan JCH; Francis BA
    Ophthalmol Glaucoma; 2019; 2(6):402-412. PubMed ID: 32672572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-Year Follow-up of MicroPulse Transscleral Laser Therapy in Patients with Primary Open-Angle Glaucoma.
    Waibel S; Herber R; Ramm L; Jasper CS; Pillunat LE; Pillunat KR
    Klin Monbl Augenheilkd; 2022 Jun; 239(6):786-792. PubMed ID: 35426110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of a Novel Zigzag Application Pattern for Micropulse Transscleral Cyclophotocoagulation for the Management of Glaucoma.
    Sami A; Aboulnasr TT; El-Shahed AF
    J Glaucoma; 2023 May; 32(5):382-388. PubMed ID: 35980854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Micropulse transscleral cyclophotocoagulation: initial results using a reduced energy protocol in refractory glaucoma.
    Vig N; Ameen S; Bloom P; Crawley L; Normando E; Porteous A; Ahmed F
    Graefes Arch Clin Exp Ophthalmol; 2020 May; 258(5):1073-1079. PubMed ID: 32036425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Repeated Micropulse Transscleral Diode Cyclophotocoagulation in Advanced Glaucoma.
    Lim EJY; Aquino CM; Lun KWX; Lim DKA; Sng C; Loon SC; Chew PTK; Koh VTC
    J Glaucoma; 2021 Jul; 30(7):566-574. PubMed ID: 33927146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Micropulse Transscleral Cyclophotocoagulation: A Look at Long-Term Effectiveness and Outcomes.
    Sarrafpour S; Saleh D; Ayoub S; Radcliffe NM
    Ophthalmol Glaucoma; 2019; 2(3):167-171. PubMed ID: 32672586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Efficacy and Safety Outcomes of Micropulse Transscleral Diode Cyclophotocoagulation in Patients With Advanced Glaucoma.
    Lim EJY; Cecilia AM; Lim DKA; Sng CCA; Loon SC; Lun KWX; Chew PTK; Koh VTC
    J Glaucoma; 2021 Mar; 30(3):257-265. PubMed ID: 33137020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term outcomes of micropulse transscleral cyclophotocoagulation as a primary versus additional therapy in eyes with uncontrolled glaucoma.
    Rajendrababu S; Senthilkumar VA; Tara TD; Uduman MS; Aila LA; Shukla AG
    Indian J Ophthalmol; 2023 Jan; 71(1):140-145. PubMed ID: 36588224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.